Dexcom (DXCM) shares slipped in midday trade on Tuesday after short seller Hunterbrook reported three additional deaths ...
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between ...
Investing.com -- DexCom (NASDAQ:DXCM) stock fell 4% Tuesday after a concerning report from Hunterbrook detailed multiple deaths allegedly linked to the company’s G7 continuous glucose monitor.
The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...
A private college and its fin-medtech partner are developing Singapore’s first AI-enabled education pathway to train ...
Oprah Daily on MSN
Hotels We Love: Six Senses Duoro Valley, Portugal
When I tell one of my favorite no-nonsense journeywomen in the wellness world—Schuyler Grant (of Kula and One Commune fame) ...
Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.
ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback